2.1
Ritlecitinib (Litfulo, Pfizer) is indicated for 'the treatment of severe alopecia areata in adults and adolescents 12 years of age and older'.
Draft guidance consultation
Closed for comments This consultation ended on at Request commenting lead permission
2 Information about ritlecitinib
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for ritlecitinib.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions